Naproxen Aristo (Naproxen)

Naproxen works by non‑selectively inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which blocks the conversion of arachidonic acid into prostaglandins. The resulting decrease in prostaglandin levels reduces inflammation, pain signaling, and fever generation.

The appropriate dose of Naproxen Aristo is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Naproxen Aristo in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs the risk, and the decision must be made by a qualified healthcare provider after evaluating the individual situation.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Naproxen Aristo. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with ibuprofen, another widely used NSAID, naproxen has a longer half‑life, allowing less frequent dosing. Both share similar efficacy for pain and inflammation, but naproxen may carry a slightly higher risk of gastrointestinal irritation, while ibuprofen is often preferred for short‑term use.

Naproxen Aristo should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain its stability and potency throughout its shelf life.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food or milk may reduce gastrointestinal discomfort. Patients should swallow tablets whole and not crush or chew them unless instructed otherwise.

Serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, severe renal impairment, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Any signs of these conditions require immediate medical attention.

Naproxen Aristo should be avoided in individuals with a known hypersensitivity to naproxen, aspirin or other NSAIDs, those with active gastrointestinal ulceration or bleeding, patients with severe heart failure, uncontrolled hypertension, or advanced renal or hepatic disease, unless a physician determines that benefits outweigh the risks.